Our mission is to disrupt “Big Pharma” to improve the quality of life of patients with chronic intestinal disease.

Based on Fecal Microbiota Transplantation (FMT) technology, we manufacture specially developed production apparatus for production of our patented FMT capsules. FMT basically works by the fact that feces from a healthy donor changes the intestinal environment and microbiota in disease by outcompeting existing microbiota and restoring balance in the intestinal microbiota. Our product is administered by the patient. We collaborate with Hvidovre Hospital, Infectious Disease Department, Microbiology Department and Gastrointestinal unit, which uses our FMT capsules to treat patients infected with antibiotic-resistant Clostridium difficile and for research purposes.

Our product empowers hospitals to make their own Fecal Microbiota Transplantation (FMT) products cheaply and effectively to treat patients, and democratizing the production of FMT will improve patient quality of life.